// App-Quantinova.ai

968 : Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer

Researchers

Presenter

  • Yuji Toiyama

Principal Investigators

  • Hiroki Imaoka

  • Hiroyuki Fujikawa

  • Junichiro Hiro

  • Susumu Saigusa

  • Koji Tanaka

  • Yasuhiro Inoue

  • Yasuhiko Mohri

  • Takao Mori

  • Toshio Kato

  • Ajay Goel

  • Masato Kusunoki

Medical Centers

  • Institute of Life Sciences, Mie University Graduate School of Medicine, Tsu, Japan

  • Moriei Hospital, Kuwana, Japan

  • Tohyama Hospital, Tsu, Japan

  • Center for Gastrointestinal Cancer Research Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A Sammons Cancer Center, Baylor University Medical Center, TX.

Locations

  • United States

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • microRNA-1290

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final